Pfizer is ditching its plans for a potentially lucrative weight loss pill after trials showed it caused significant side effects. The firm had said oral obesity pills could create more than $10bn in future revenues.
Apparently, the pill, danuglipron, caused high rates of gastrointestinal side effects, with up to 73 % of participants taking the drug suffering nausea and up to 47% vomiting.
Perhaps initially less food and more exercise would be a good idea, instead of using quick-fix controversial drugs – or is such an old -fashioned notion a wee bit to radical (and let’s say ‘heretical’) in these times of the well-trained public trusting Big Pharma with many aspects of their lives?
It is however noted that certain medical conditions may require medical intervention when weight loss is vital.
https://www.ft.com/content/510f64c0-75d6-4d69-b59a-a8d196a29a7e
No comments:
Post a Comment